Selected research
Market Outlook & Growth Opportunities
Global DNA Synthesis Service Market Outlook and Growth Opportunities 2026
Market perspective
The global DNA Synthesis Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for DNA Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for DNA Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for DNA Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the DNA Synthesis Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the DNA Synthesis Service market include Genescript, Thermo Fisher Scientific, IDT, Eurofins Genomics, DNA 2.0 (ATUM), BBI, Azenta Life Sciences, SBS Genetech and Bio Basic, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global DNA Synthesis Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of DNA Synthesis Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents DNA Synthesis Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global DNA Synthesis Service market.
DNA Synthesis Service Segment by Company
Genescript
Thermo Fisher Scientific
IDT
Eurofins Genomics
DNA 2.0 (ATUM)
BBI
Azenta Life Sciences
SBS Genetech
Bio Basic
Twist Bioscience
OriGene
Bioneer
Eton Bioscience
Synbio Technologies
Eurogentec
DNA Synthesis Service Segment by Type
Oligonucleotide Synthesis
Gene Synthesis
DNA Synthesis Service Segment by Application
Commercial
Academic Research
DNA Synthesis Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global DNA Synthesis Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the DNA Synthesis Service key companies, revenue, market share, and recent developments.
3. To split the DNA Synthesis Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions DNA Synthesis Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify DNA Synthesis Service significant trends, drivers, influence factors in global and regions.
6. To analyze DNA Synthesis Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Synthesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA Synthesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Synthesis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global DNA Synthesis Service industry.
Chapter 3: Detailed analysis of DNA Synthesis Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of DNA Synthesis Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of DNA Synthesis Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Oligonucleotide Synthesis
- Gene Synthesis
Applications
- Commercial
- Academic Research
Companies covered
- Genescript
- Thermo Fisher Scientific
- IDT
- Eurofins Genomics
- DNA 2.0 (ATUM)
- BBI
- Azenta Life Sciences
- SBS Genetech
- Bio Basic
- Twist Bioscience
- OriGene
- Bioneer
- Eton Bioscience
- Synbio Technologies
- Eurogentec
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global DNA Synthesis Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global DNA Synthesis Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 DNA Synthesis Service Market Dynamics
- 2.1 DNA Synthesis Service Industry Trends
- 2.2 DNA Synthesis Service Industry Drivers
- 2.3 DNA Synthesis Service Industry Opportunities and Challenges
- 2.4 DNA Synthesis Service Industry Restraints
3 DNA Synthesis Service Market by Company
- 3.1 Global DNA Synthesis Service Company Revenue Ranking in 2025
- 3.2 Global DNA Synthesis Service Revenue by Company (2021-2026)
- 3.3 Global DNA Synthesis Service Company Ranking (2024-2026)
- 3.4 Global DNA Synthesis Service Company Manufacturing Base and Headquarters
- 3.5 Global DNA Synthesis Service Company Product Type and Application
- 3.6 Global DNA Synthesis Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global DNA Synthesis Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 DNA Synthesis Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 DNA Synthesis Service Market by Type
- 4.1 DNA Synthesis Service Type Introduction
- 4.1.1 Oligonucleotide Synthesis
- 4.1.2 Gene Synthesis
- 4.2 Global DNA Synthesis Service Sales Value by Type
- 4.2.1 Global DNA Synthesis Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global DNA Synthesis Service Sales Value by Type (2021-2032)
- 4.2.3 Global DNA Synthesis Service Sales Value Share by Type (2021-2032)
5 DNA Synthesis Service Market by Application
- 5.1 DNA Synthesis Service Application Introduction
- 5.1.1 Commercial
- 5.1.2 Academic Research
- 5.2 Global DNA Synthesis Service Sales Value by Application
- 5.2.1 Global DNA Synthesis Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global DNA Synthesis Service Sales Value by Application (2021-2032)
- 5.2.3 Global DNA Synthesis Service Sales Value Share by Application (2021-2032)
6 DNA Synthesis Service Regional Value Analysis
- 6.1 Global DNA Synthesis Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global DNA Synthesis Service Sales Value by Region (2021-2032)
- 6.2.1 Global DNA Synthesis Service Sales Value by Region: 2021-2026
- 6.2.2 Global DNA Synthesis Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America DNA Synthesis Service Sales Value (2021-2032)
- 6.3.2 North America DNA Synthesis Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe DNA Synthesis Service Sales Value (2021-2032)
- 6.4.2 Europe DNA Synthesis Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific DNA Synthesis Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific DNA Synthesis Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America DNA Synthesis Service Sales Value (2021-2032)
- 6.6.2 South America DNA Synthesis Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa DNA Synthesis Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa DNA Synthesis Service Sales Value Share by Country, 2025 VS 2032
7 DNA Synthesis Service Country-level Value Analysis
- 7.1 Global DNA Synthesis Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global DNA Synthesis Service Sales Value by Country (2021-2032)
- 7.2.1 Global DNA Synthesis Service Sales Value by Country (2021-2026)
- 7.2.2 Global DNA Synthesis Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt DNA Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Genescript
- 8.1.1 Genescript Company Information
- 8.1.2 Genescript Business Overview
- 8.1.3 Genescript DNA Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Genescript DNA Synthesis Service Product Portfolio
- 8.1.5 Genescript Recent Developments
- 8.2 Thermo Fisher Scientific
- 8.2.1 Thermo Fisher Scientific Company Information
- 8.2.2 Thermo Fisher Scientific Business Overview
- 8.2.3 Thermo Fisher Scientific DNA Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.2.4 Thermo Fisher Scientific DNA Synthesis Service Product Portfolio
- 8.2.5 Thermo Fisher Scientific Recent Developments
- 8.3 IDT
- 8.3.1 IDT Company Information
- 8.3.2 IDT Business Overview
- 8.3.3 IDT DNA Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.3.4 IDT DNA Synthesis Service Product Portfolio
- 8.3.5 IDT Recent Developments
- 8.4 Eurofins Genomics
- 8.4.1 Eurofins Genomics Company Information
- 8.4.2 Eurofins Genomics Business Overview
- 8.4.3 Eurofins Genomics DNA Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Eurofins Genomics DNA Synthesis Service Product Portfolio
- 8.4.5 Eurofins Genomics Recent Developments
- 8.5 DNA 2.0 (ATUM)
- 8.5.1 DNA 2.0 (ATUM) Company Information
- 8.5.2 DNA 2.0 (ATUM) Business Overview
- 8.5.3 DNA 2.0 (ATUM) DNA Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.5.4 DNA 2.0 (ATUM) DNA Synthesis Service Product Portfolio
- 8.5.5 DNA 2.0 (ATUM) Recent Developments
- 8.6 BBI
- 8.6.1 BBI Company Information
- 8.6.2 BBI Business Overview
- 8.6.3 BBI DNA Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.6.4 BBI DNA Synthesis Service Product Portfolio
- 8.6.5 BBI Recent Developments
- 8.7 Azenta Life Sciences
- 8.7.1 Azenta Life Sciences Company Information
- 8.7.2 Azenta Life Sciences Business Overview
- 8.7.3 Azenta Life Sciences DNA Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Azenta Life Sciences DNA Synthesis Service Product Portfolio
- 8.7.5 Azenta Life Sciences Recent Developments
- 8.8 SBS Genetech
- 8.8.1 SBS Genetech Company Information
- 8.8.2 SBS Genetech Business Overview
- 8.8.3 SBS Genetech DNA Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.8.4 SBS Genetech DNA Synthesis Service Product Portfolio
- 8.8.5 SBS Genetech Recent Developments
- 8.9 Bio Basic
- 8.9.1 Bio Basic Company Information
- 8.9.2 Bio Basic Business Overview
- 8.9.3 Bio Basic DNA Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Bio Basic DNA Synthesis Service Product Portfolio
- 8.9.5 Bio Basic Recent Developments
- 8.10 Twist Bioscience
- 8.10.1 Twist Bioscience Company Information
- 8.10.2 Twist Bioscience Business Overview
- 8.10.3 Twist Bioscience DNA Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Twist Bioscience DNA Synthesis Service Product Portfolio
- 8.10.5 Twist Bioscience Recent Developments
- 8.11 OriGene
- 8.11.1 OriGene Company Information
- 8.11.2 OriGene Business Overview
- 8.11.3 OriGene DNA Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.11.4 OriGene DNA Synthesis Service Product Portfolio
- 8.11.5 OriGene Recent Developments
- 8.12 Bioneer
- 8.12.1 Bioneer Company Information
- 8.12.2 Bioneer Business Overview
- 8.12.3 Bioneer DNA Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.12.4 Bioneer DNA Synthesis Service Product Portfolio
- 8.12.5 Bioneer Recent Developments
- 8.13 Eton Bioscience
- 8.13.1 Eton Bioscience Company Information
- 8.13.2 Eton Bioscience Business Overview
- 8.13.3 Eton Bioscience DNA Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.13.4 Eton Bioscience DNA Synthesis Service Product Portfolio
- 8.13.5 Eton Bioscience Recent Developments
- 8.14 Synbio Technologies
- 8.14.1 Synbio Technologies Company Information
- 8.14.2 Synbio Technologies Business Overview
- 8.14.3 Synbio Technologies DNA Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.14.4 Synbio Technologies DNA Synthesis Service Product Portfolio
- 8.14.5 Synbio Technologies Recent Developments
- 8.15 Eurogentec
- 8.15.1 Eurogentec Company Information
- 8.15.2 Eurogentec Business Overview
- 8.15.3 Eurogentec DNA Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.15.4 Eurogentec DNA Synthesis Service Product Portfolio
- 8.15.5 Eurogentec Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst